CNS Share Price

CNS Share Price

NASDAQ: CNSP | Healthcare
$0.00
-$3.95 (--%)
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • Similar Stocks
  • FAQs

CNS Stock Performance

Open
N/A
Prev. Close
$3.95
Circuit Range
N/A
Day Range
N/A
Year Range
$1.91 - $10.41
Volume
N/A
Average Traded
N/A

CNS Share Price Chart

Line chart of the CNS price trend over the selected period. The price fell overall, ranging from 3.95 to 3.95, ending at 3.95.
$0.00$0.00
L
Show Current Price
H

CNS Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-10.83
Revenue (TTM)
$0.00
Return On Equity (TTM)
-101.75%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
58.05%

CNS Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$5.96-$4.94-$2.59-$2.50
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A17.11%47.57%3.47%

CNS Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$15.27-$18.85-$14.86-$15.85
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-23.44%21.17%-6.66%

CNS Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.520.040.110.49
Current Assets8.18.661.5912.56
Total Assets8.628.71.713.05
Non Current Liabilities0.00.00.00.0
Current Liabilities4.12.526.134.92
Total Liabilities4.12.526.134.92
Shareholders' Equity4.526.18-4.438.13

CNS Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-13.81-17.11-14.14-10.56
Investing-0.020.00.00.0
Financing14.5723.034.6415.61

Corporate Actions

Split
Ex-date: 22 Jul 2025

Split
Ex-date: 21 Feb 2025

Split
Ex-date: 05 Jun 2024

Split
Ex-date: 29 Nov 2022

About CNS

CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.

CNS Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$4.39
$3.95
-18.72%
Oct 2026
$5.45
$4.86
-18.04%
Sep 2026
$5.80
$5.93
+8.81%
Aug 2026
$5.45
$5.45
-6.03%
Jul 2026
$4.88
$5.80
+37.44%
Jun 2026
$5.11
$4.22
-16.27%
May 2026
$9.17
$5.04
+129.09%
Apr 2026
$2.27
$2.20
-4.76%
Mar 2026
$3.13
$2.31
-26.67%
Feb 2026
$5.38
$3.15
-44.25%
Jan 2026
$5.62
$5.65
+8.03%
Dec 2025
$6.81
$5.23
-25.29%

Similar Stocks

CNS Share Price FAQs